Sea Crest Wealth Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$120.42 - $169.29 $36,126 - $50,787	300 New	300 $44,000
Q2 2019 Jul 19, 2019	SELL	$65.86 - $92.79 $26,344 - $37,116	-400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $8,752 - $12,267	100 Added 33.33%	400 $35,000
Q2 2018 Aug 03, 2018	SELL	$88.31 - $107.8 $8,831 - $10,780	-100 Reduced 25.0%	300 $30,000
Q4 2017 Feb 02, 2018	BUY	$114.49 - $139.98 $45,796 - $55,991	400	400 $51,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.